SOUTH SAN FRANCISCO, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (DNLI) today reported financial results for the fourth quarter and year ended December 31, 2024, and provided ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback